Understanding the Benefit of Combining GLP-1 Agonists With Exercise: Time Will Tell

J Clin Endocrinol Metab. 2024 Jan 18;109(2):e860-e861. doi: 10.1210/clinem/dgad426.
No abstract available

Keywords: glycemic control; insulin sensitivity; pancreatic function; physical activity; type 2 diabetes; weight loss.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / physiopathology
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptides*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use

Substances

  • semaglutide
  • Hypoglycemic Agents
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptides